NecroX-5 exerts anti-inflammatory and anti-fibrotic effects via modulation of the TNFα/Dcn/TGFβ1/Smad2 pathway in hypoxia/reoxygenation-treated rat hearts

다국어 초록 (Multilingual Abstract)

Inflammatory and fibrotic responses are accelerated during the reperfusion period, and excessive fibrosis and inflammation contribute to cardiac malfunction. NecroX compounds have been shown to protect the liver and heart from ischemia-reperfusion injury. The aim of this study was to further define the role and mechanism of action of NecroX-5 in regulating infl ammation and fi brosis responses in a model of hypoxia/reoxygenation (HR). We utilized HR-treated rat hearts and lipopolysaccharide (LPS)-treated H9C2 culture cells in the presence or absence of NecroX-5 (10 μmol/L) treatment as experimental models. Addition of NecroX-5 signifi cantly increased decorin (Dcn) expression levels in HR-treated hearts. In contrast, expression of transforming growth factor beta 1 (TGFβ1) and Smad2 phosphorylation (pSmad2) was strongly attenuated in NecroX-5-treated hearts. In addition, signifi cantly increased production of tumor necrosis factor alpha (TNFα), TGFβ1, and pSmad2, and markedly decreased Dcn expression levels, were observed in LPS-stimulated H9C2 cells. Interestingly, NecroX-5 supplementation effectively attenuated the increased expression levels of TNFα, TGFβ1, and pSmad2, as well as the decreased expression of Dcn. Thus, our data demonstrate potential anti-inflammatory and anti-fibrotic effects of NecroX-5 against cardiac HR injuries via modulation of the TNFα/Dcn/TGFβ1/Smad2 pathway.

참고문헌 (Reference)

1 Kuwahara F, "Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressureoverloaded rats" 106 : 130-135, 2002

2 Ständer M, "Transforming growth factor-beta and p-21 : multiple molecular targets of decorin-mediated suppression of neoplastic growth" 296 : 221-227, 1999

3 Doi M, "Time-dependent changes of decorin in the infarct zone after experimentally induced myocardial infarction in rats : comparison with biglycan" 196 : 23-33, 2000

4 Zimmerman SD, "Time course of collagen and decorin changes in rat cardiac and skeletal muscle post-MI" 281 : 1816-1822, 2001

5 Bujak M, "The role of TGF-beta signaling in myocardial infarction and cardiac remodeling" 74 : 184-195, 2007

6 Kanzleiter T, "The myokine decorin is regulated by contraction and involved in muscle hypertrophy" 450 : 1089-1094, 2014

7 McLeod CJ, "The mitochondrial biogenesis regulatory program in cardiac adaptation to ischemia--a putative target for therapeutic intervention" 15 : 118-123, 2005

8 Steffens S, "The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury" 102 : 240-247, 2009

9 Järvinen TA, "Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice" 107 : 21671-21676, 2010

10 Kleinbongard P, "TNFα in myocardial ischemia/reperfusion, remodeling and heart failure" 16 : 49-69, 2011

11 Schulz R, "TNFalpha in ischemia/reperfusion injury and heart failure" 99 : 8-11, 2004

12 Mohan RR, "Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy" 52 : 4833-4841, 2011

13 Szklarczyk D, "STRING v10 : protein-protein interaction networks, integrated over the tree of life" 43 : 447-452, 2015

14 Russell ST, "Role of reactive oxygen species in protein degradation in murine myotubes induced by proteolysisinducing factor and angiotensin II" 19 : 1797-1806, 2007

15 Chandel NS, "Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin" 165 : 1013-1021, 2000

16 Bruckner BA, "Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support" 20 : 457-464, 2001

17 Piper HM, "Reducing the impact of myocardial ischaemia/reperfusion injury" 94 : 165-167, 2012

18 Song JJ, "Protective role of NecroX-5against neomycin-induced hair cell damage in zebrafish" 88 : 435-441, 2014

19 Alan C, "Protective effect of decorin on acute ischaemia-reperfusion injury in the rat kidney" 7 : 211-216, 2011

20 Park MK, "Protective effect of NecroX, a novel necroptosis inhibitor, on gentamicininduced ototoxicity" 76 : 1265-1269, 2012

21 Kim N, "Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics" 6 : 1237-1249, 2006

22 Li L, "Postinfarction gene therapy with adenoviral vector expressing decorin mitigates cardiac remodeling and dysfunction" 297 : 1504-1513, 2009

23 Carden DL, "Pathophysiology of ischaemia-reperfusion injury" 190 : 255-266, 2000

24 Ding G, "PPARdelta modulates lipopolysaccharide-induced TNFalpha inflammation signaling in cultured cardiomyocytes" 40 : 821-828, 2006

25 Lee SR, "NecroX-5 suppresses sodium nitroprusside-induced cardiac cell death through inhibition of JNK and caspase-3 activation" 38 : 702-707, 2014

26 Vu Thi Thu, "NecroX-5 protects mitochondrial oxidative phosphorylation capacity and preserves PGC1α expression levels during hypoxia/ reoxygenation injury" 대한약리학회 20 (20): 201-211, 2016

27 Thu VT, "NecroX-5 prevents hypoxia/reoxygenation injury by inhibiting the mitochondrial calcium uniporter" 94 : 342-350, 2012

28 Hyoung Jin Kim, "NecroX as a Novel Class of Mitochondrial Reactive Oxygen Species and ONOO− Scavenger" 대한약학회 33 (33): 1813-1823, 2010

29 Kim SR, "NLRP3inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation" 5 : 1498-, 2014

30 Naik E, "Mitochondrial reactive oxygen species drive proinflammatory cytokine production" 208 : 417-420, 2011

31 López-Armada MJ, "Mitochondrial dysfunction and the inflammatory response" 13 : 106-118, 2013

32 Dada LA, "Mitochondrial Ca²+ and ROS take center stage to orchestrate TNF--mediated inflammatory responses" 121 : 1683-1685, 2011

33 Takaseya T, "Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy" 44 : 2239-2246, 2004

34 Mosca S, "Ischemic cardiovascular involvement in psoriasis : a systematic review" 178 : 191-199, 2015

35 Edwards IJ, "Interleukin-1 upregulates decorin production by arterial smooth muscle cells" 14 : 1032-1039, 1994

36 Groeneveld TW, "Interactions of the extracellular matrix proteoglycans decorin and biglycan with C1q and collectins" 175 : 4715-4723, 2005

37 Ma M, "Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril" 38 (38): 51-54, 2001

38 Bjørnstad JL, "Inhibition of SMAD2phosphorylation preserves cardiac function during pressure overload" 93 : 100-110, 2012

39 Nian M, "Inflammatory cytokines and postmyocardial infarction remodeling" 94 : 1543-1553, 2004

40 Hunter RL, "Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system" 100 : 1375-1386, 2007

41 Lijnen PJ, "Induction of cardiac fibrosis by transforming growth factor-beta(1)" 71 : 418-435, 2000

42 Mauviel A, "Induction by quiescence and repression by tumor necrosis factor-alpha" 270 : 11692-11700, 1995

43 Mogyorosi A, "Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose" 275 : 827-832, 1998

44 Mauviel A, "Identification of a bimodal regulatory element encompassing a canonical AP-1 binding site in the proximal promoter region of the human decorin gene" 271 : 24824-24829, 1996

45 Kim HK, "Human giant congenital melanocytic nevus exhibits potential proteomic alterations leading to melanotumorigenesis" 10 : 50-, 2012

46 Isaka Y, "Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney" 2 : 418-423, 1996

47 Jalil JE, "Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle" 64 : 1041-1050, 1989

48 Louise Anne Dizon, "Exercise perspective on common cardiac medications" 한국한의학연구원 2 (2): 49-55, 2013

49 Hao J, "Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing" 31 : 667-678, 1999

50 Choi JM, "Effect of necrosis modulator necrox-7 on hepatic ischemiareperfusion injury in beagle dogs" 42 : 3414-3421, 2010

51 Beanes SR, "Downregulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing" 36 : 1666-1671, 2001

52 Kähäri VM, "Differential regulation of decorin and biglycan gene expression by dexamethasone and retinoic acid in cultured human skin fibroblasts" 104 : 503-508, 1995

53 Samet Yilmaz, "Diabetic Cardiomyopathy; Summary of 41 Years" 대한심장학회 45 (45): 266-272, 2015

54 Bruckner BA, "Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support" 23 : 36-42, 2004

55 Jubert Marquez, "Definitely not lost in translation: post-translational modifications of cardiac mitochondrial proteins in cardiovascular disease" 대한심장학회 46 (46): 1-12, 2016

56 Jahanyar J, "Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling" 26 : 34-40, 2007

57 Costacurta A, "Decorin transfection in human mesangial cells downregulates genes playing a role in the progression of fibrosis" 16 : 178-186, 2002

58 Abdel-Wahab N, "Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240" 362 : 643-649, 2002

59 Yan W, "Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38mitogen-activated protein kinase signaling pathways" 20 : 1190-1200, 2009

60 Burlew BS, "Connective tissue and the heart. Functional significance and regulatory mechanisms" 18 : 435-442, 2000

61 Deten A, "Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats" 33 : 1191-1207, 2001

62 Giri SN, "Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis" 54 : 1205-1216, 1997

63 Simkhovich BZ, "Agerelated changes of cardiac gene expression following myocardial ischemia/reperfusion" 420 : 268-278, 2003

64 Weis SM, "A role for decorin in the remodeling of myocardial infarction" 24 : 313-324, 2005

65 Halestrap AP, "A pore way to die : the role of mitochondria in reperfusion injury and cardioprotection" 38 : 841-860, 2010

66 Cabello-Verrugio C, "A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1" 282 : 18842-18850, 2007